Niloufar Bineshfar, Faraz Changizi, Mina Farjam, Faezeh Sharafi, Basil K Williams
{"title":"Systematic Review and Meta-Analysis of OCT measurements in patients with chronic kidney disease.","authors":"Niloufar Bineshfar, Faraz Changizi, Mina Farjam, Faezeh Sharafi, Basil K Williams","doi":"10.1097/IAE.0000000000004377","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess neurodegeneration and chorioretinal thickness in subjects with and without chronic kidney disease (CKD).</p><p><strong>Methods: </strong>PubMed, Web of Science, Scopus and Embase were searched using proper keywords for articles published in the English language from their inception until January 2024. Publications were included if they reported optical coherence tomography (OCT) measurements of retinal or choroidal layers in patients with CKD compared to healthy or non-CKD controls. We used a random-effects model to calculate pooled standardized mean difference (SMD) estimates and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Twelve studies, with 29,340 patients, were included in quantitative synthesis. In comparison to controls, patients with CKD had a significantly lower value for average retinal thickness (SMD [CI]: -0.35 [-0.58; -0.12], P = 0.028), choroidal thickness (SMD [CI]: -1.84 [-4.17; 0.49], P = 0.122), macular ganglion cell-inner plexiform layer (GC-IPL) (SMD [CI]: -0.58 [-0.78; -0.38]], P < 0.001), and peripapillary retinal nerve fiber layer (RNFL) thickness (SMD [CI]: -0.32 [-0.44; -0.20], P < 0.001). Significant RNFL thinning was observed in both diabetic CKD excluded and not excluded subgroups.</p><p><strong>Conclusion: </strong>Compared to controls, the eyes of patients with CKD have significantly thinner retina, GC-IPL, and RNFL.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004377","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To assess neurodegeneration and chorioretinal thickness in subjects with and without chronic kidney disease (CKD).
Methods: PubMed, Web of Science, Scopus and Embase were searched using proper keywords for articles published in the English language from their inception until January 2024. Publications were included if they reported optical coherence tomography (OCT) measurements of retinal or choroidal layers in patients with CKD compared to healthy or non-CKD controls. We used a random-effects model to calculate pooled standardized mean difference (SMD) estimates and 95% confidence intervals (CIs).
Results: Twelve studies, with 29,340 patients, were included in quantitative synthesis. In comparison to controls, patients with CKD had a significantly lower value for average retinal thickness (SMD [CI]: -0.35 [-0.58; -0.12], P = 0.028), choroidal thickness (SMD [CI]: -1.84 [-4.17; 0.49], P = 0.122), macular ganglion cell-inner plexiform layer (GC-IPL) (SMD [CI]: -0.58 [-0.78; -0.38]], P < 0.001), and peripapillary retinal nerve fiber layer (RNFL) thickness (SMD [CI]: -0.32 [-0.44; -0.20], P < 0.001). Significant RNFL thinning was observed in both diabetic CKD excluded and not excluded subgroups.
Conclusion: Compared to controls, the eyes of patients with CKD have significantly thinner retina, GC-IPL, and RNFL.
期刊介绍:
RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice.
In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color.
Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.